A large body of evidence supports the idea that MYC can profoundly shape the metabolic state of cancer cells by regulating a plethora of processes such as glutamine synthesis, glycolysis and lipogenesis as well as mitochondrial biogenesis and metabolism. The gene discussed is MYC; the disease is cancer.